Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center

Abstract

Objectives. There have been no reported data on the medical care cost of idiopathic peptic ulcer disease (PUD) compared with H. pylori (+) and/or NSAID (+) cases although H. pylori-negative idiopathic ulcers are increasing. The aim of this study was to investigate the direct medical care costs of PUD based on whether it was H. pylori infection/from NSAIDs or idiopathic. Material and methods. One hundred and seventy three patients with PUD comprising H. pylori and/or NSAID use-associated PUD (n = 145) and idiopathic PUD (n = 28) were prospectively enrolled in this study. The direct medical care costs were analyzed retrospectively for the patients with PUD during a one-year follow-up period. Results. The recurrence rate within one year was significantly higher in idiopathic PUD than H. pylori and/or NSAID-associated PUD (p = 0.002). Direct medical care costs of idiopathic PUD ($2483.8) were higher than in patients with H. pylori and/or NSAID-associated PUD ($1751.8) resulting from longer duration of medication and higher proportion of endoscopic hemostasis and hospitalization. Conclusions. More clinical research is needed to improve outcome and reduce recurrence rate and medical care costs of idiopathic PUD.

Key Words::

• health care costs
• Helicobacter pylori
• NSAIDs
• peptic ulcer

Acknowledgements

This work was supported by a grant (no. 06-2010-084) from the Seoul National University Bundang Hospital research fund.

Declaration of interest: No author has conflicts of interest or financial arrangements that could potentially influence the described research.